bioAffinity Technologies, Inc.BIAF

$0.84+0.01 (+0.65%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$4M

Micro-cap

-65%

2022 — today

10-Year Price

-99%

2022 — today

52-Week Range

$0.75$10.95

Current $0.84· 1%

As a biotechnology enterprise, bioAffinity Technologies, Inc. is dedicated to pioneering both non-invasive diagnostic solutions and precision therapeutics for cancer. Its portfolio features CyPath lung, a specialized diagnostic test designed for the early identification of lung cancer. Beyond diagnostics, the firm actively explores targeted therapies intended to combat cancer at a cellular level. This San Antonio, Texas-based company commenced operations in 2014.

Valuation in context

P/E ratio

-0.1

N/A

Not meaningful — company is unprofitable

P/B ratio

1.0

Below average

Below the 10-year average

FCF Yield

-288.8%

Historically low

Historically low relative to the last 10 years

Free · No credit card needed

Get alerted when BIAF is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.